Position in AMGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$335,323
+$27,807 QoQ
Shares Held
926
+5.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#2,476
of 3,140 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traveka Wealth, LLC holds $7,683,360 across 9 Drug Manufacturers - General names. AMGN ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,362 | $2,833,053 | |
| 2 | JNJ |
Johnson & Johnson
|
6,397 | $1,624,646 | |
| 3 | ABBV |
AbbVie Inc.
|
3,731 | $938,868 | |
| 4 | AZN |
Astrazeneca PLC
|
3,416 | $647,741 | |
| 5 | NVS |
Novartis AG
|
3,165 | $496,018 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,711 | $348,363 | |
| 7 | AMGN |
Amgen Inc
This page
|
926 | $335,323 | |
| 8 | NVO |
Novo Nordisk A S
|
5,265 | $252,404 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $335,323 | 926 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $307,516 | 874 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $222,898 | 681 | Shares | Sole | 2026-01-08 | |
| 2025-03-31 | $228,989 | 735 | Shares | Sole | 2025-04-29 | |
| 2024-09-30 | $260,023 | 807 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $241,836 | 774 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $213,240 | 750 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $200,749 | 697 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||